These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 18628426
1. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Li H, Hao X, Zhang W, Wei Q, Chen K. Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426 [Abstract] [Full Text] [Related]
2. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, Pang D, Li D. Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067 [Abstract] [Full Text] [Related]
3. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Gu D, Wang M, Zhang Z, Chen J. Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639 [Abstract] [Full Text] [Related]
4. Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Chang CH, Hsiao CF, Chang GC, Tsai YH, Chen YM, Huang MS, Su WC, Hsieh WS, Yang PC, Chen CJ, Hsiung CA. Am J Epidemiol; 2009 Sep 15; 170(6):695-702. PubMed ID: 19671832 [Abstract] [Full Text] [Related]
5. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, Li Z, Wang J, Takezaki T, Tajima K, Varga T, Sawaguchi T, Lum JK, Martinson JJ, Tsugane S, Iwamasa T, Shinmura K, Yokota J. Cancer Epidemiol Biomarkers Prev; 1999 Aug 15; 8(8):669-74. PubMed ID: 10744126 [Abstract] [Full Text] [Related]
6. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease. Yang SF, Xu YJ, Xie JG, Zhang ZX. Chin Med J (Engl); 2009 Apr 20; 122(8):960-6. PubMed ID: 19493423 [Abstract] [Full Text] [Related]
7. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. Okasaka T, Matsuo K, Suzuki T, Ito H, Hosono S, Kawase T, Watanabe M, Yatabe Y, Hida T, Mitsudomi T, Tanaka H, Yokoi K, Tajima K. J Hum Genet; 2009 Dec 20; 54(12):739-45. PubMed ID: 19881468 [Abstract] [Full Text] [Related]
8. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Zhong DY, Chu HY, Wang ML, Ma L, Shi DN, Zhang ZD. Genet Mol Res; 2012 Sep 26; 11(3):3490-6. PubMed ID: 23079842 [Abstract] [Full Text] [Related]
9. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls. Ni M, Qiu J, He W, Wang X. Eur J Gastroenterol Hepatol; 2012 Jun 26; 24(6):683-7. PubMed ID: 22343785 [Abstract] [Full Text] [Related]
10. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Hung RJ, Hall J, Brennan P, Boffetta P. Am J Epidemiol; 2005 Nov 15; 162(10):925-42. PubMed ID: 16221808 [Abstract] [Full Text] [Related]
11. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis. Li D, Liu H, Yan L, Tang Y, Ren J, Xu Z. Urol Int; 2012 Nov 15; 88(1):88-94. PubMed ID: 22156293 [Abstract] [Full Text] [Related]
12. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Borel S, Hall J, Boffetta P. J Natl Cancer Inst; 2005 Apr 20; 97(8):567-76. PubMed ID: 15840879 [Abstract] [Full Text] [Related]
13. hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Li Q, Huang L, Rong L, Xue Y, Lu Q, Rui Y, Li J, Tong N, Wang M, Zhang Z, Fang Y. Cancer Sci; 2011 Jun 20; 102(6):1123-7. PubMed ID: 21401806 [Abstract] [Full Text] [Related]
14. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies. Wang W, Wang M, Chen Y, Zhang Z, Wang S, Xu M, Wang B, Zhao Q, Zhang Z. Mutagenesis; 2012 May 20; 27(3):329-36. PubMed ID: 22121210 [Abstract] [Full Text] [Related]
15. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies. Guo CL, Han FF, Wang HY, Wang L. J Cancer Res Clin Oncol; 2012 Sep 20; 138(9):1443-8. PubMed ID: 22526153 [Abstract] [Full Text] [Related]
16. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis. Coppedè F, Mancuso M, Lo Gerfo A, Carlesi C, Piazza S, Rocchi A, Petrozzi L, Nesti C, Micheli D, Bacci A, Migliore L, Murri L, Siciliano G. Neurosci Lett; 2007 Jun 13; 420(2):163-8. PubMed ID: 17531381 [Abstract] [Full Text] [Related]
17. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer. Hu YC, Ahrendt SA. Int J Cancer; 2005 Apr 10; 114(3):387-93. PubMed ID: 15551330 [Abstract] [Full Text] [Related]
18. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan J, Zhu M, Hu Q, Wang Q, Wang Z, Yan Z, Jin K, Zhou D, Xuan F, Huang X, Shao J, Lu P. PLoS One; 2011 Apr 10; 6(11):e27545. PubMed ID: 22114677 [Abstract] [Full Text] [Related]
19. [Genetic polymorphism in hOGG1 and susceptibility to esophageal cancer in Chinese]. Xing D, Tan W, Song N, Lin D. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec 10; 17(6):377-80. PubMed ID: 11110971 [Abstract] [Full Text] [Related]
20. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2'-deoxyguanosine DNA glycosylase 1. Lee AJ, Hodges NJ, Chipman JK. Cancer Epidemiol Biomarkers Prev; 2005 Feb 10; 14(2):497-505. PubMed ID: 15734978 [Abstract] [Full Text] [Related] Page: [Next] [New Search]